ALDOB K87 Lactylation Links Mitochondrial Fission to PH Prog
2026-04-27
ALDOB K87 Lactylation Drives Mitochondrial Fission in Pulmonary Hypertension
Study Background and Research Question
Pulmonary hypertension (PH) is a severe vascular disorder marked by progressive remodeling of the pulmonary arteries, leading to elevated pulmonary pressure and eventual right heart failure. Despite advances in vasodilator therapies, the fundamental molecular drivers of vascular remodeling and smooth muscle cell proliferation remain incompletely understood (Yi et al., 2026). Recent attention has turned to the role of metabolic reprogramming—specifically, the shift from oxidative phosphorylation to aerobic glycolysis (the Warburg effect)—and its impact on the proliferation and phenotype of pulmonary artery smooth muscle cells (PASMCs). However, the coupling mechanisms linking altered metabolism, mitochondrial dynamics, and epigenetic regulation in PH pathogenesis have not been fully elucidated.Key Innovation from the Reference Study
Yi et al. (2026) introduce a novel mechanistic link between lactate metabolism and mitochondrial dynamics in PH by focusing on the post-translational modification of aldolase B (ALDOB), a glycolytic enzyme. Using integrated lactylomic profiling, the authors identify lactylation of ALDOB at lysine-87 (K87) as a critical event induced by hypoxic stress in PASMCs. This modification recruits dynamin-related protein 1 (DRP1) to mitochondria after SUMO-specific peptidase 3–mediated deSUMOylation, promoting mitochondrial fission. The study positions ALDOB K87 lactylation as a pivotal regulator of both metabolic rewiring and mitochondrial fragmentation, directly contributing to the pathological proliferation and migration of PASMCs (Yi et al., 2026).Methods and Experimental Design Insights
The research employed a multifaceted experimental approach:- Lactylome sequencing was performed on hypoxic human PASMCs to map changes in protein lactylation.
- Rodent models of PH were used to validate in vitro findings and assess in vivo relevance.
- Genetic manipulation (knockdown and overexpression) of ALDOB and DRP1, along with pharmacological modulation of lactylation, were applied to dissect pathway specificity.
- Phenotypic assays measured PASMC proliferation, migration, and mitochondrial morphology under different conditions.
- Sirtuin 1 activity was analyzed as a potential delactylase regulating ALDOB lactylation status.
Protocol Parameters
- assay | hypoxic culture duration | 24-72 h | models metabolic stress in PASMCs | mimics in vivo PH conditions | paper
- assay | ALDOB knockdown efficiency | ≥80% suppression | required for phenotype rescue | ensures pathway specificity | paper
- assay | pharmacological lactylation inhibitor dose | 1-10 μM | titrated in vitro | confirms modification-dependence of phenotype | paper
- assay | cell proliferation assay with PDGF-BB | 2-10 ng/ml | positive control for mitogen responsiveness | validates PASMC proliferative capacity | workflow_recommendation
Core Findings and Why They Matter
The study provides several critical insights:- Hypoxia-Induced ALDOB K87 Lactylation: Hypoxic conditions enhance global protein lactylation, with ALDOB K87 emerging as a dominant non-histone target. This is accompanied by a self-reinforcing loop, as increased glycolytic flux generates more lactate, further driving ALDOB lactylation (Yi et al., 2026).
- Mitochondrial Fission and PASMC Proliferation: ALDOB K87 lactylation is necessary for DRP1 recruitment to mitochondria, promoting mitochondrial fragmentation—a hallmark of highly proliferative, metabolic-rewired PASMCs. Genetic or pharmacological suppression of ALDOB lactylation attenuates these effects and reduces disease progression in rodent PH models.
- Sirtuin 1 as a Negative Regulator: SIRT1, a known delactylase, is downregulated in PH, perpetuating ALDOB K87 lactylation and its downstream consequences. This identifies an additional regulatory axis that may be therapeutically exploitable.
Comparison with Existing Internal Articles
Several internal resources provide complementary context:- ALDOB K87 Lactylation Rewires Mitochondria in Pulmonary Hypertension offers a concise summary of the reference study's mechanistic insight, emphasizing the link between lactate signaling and smooth muscle cell proliferation. This aligns directly with the new evidence on ALDOB-mediated mitochondrial fission.
- Applied Workflows with Murine Recombinant PDGF-BB in Vascular Research and Optimizing Cell Proliferation Assays with Murine Recombinant PDGF-BB detail how PDGF-BB, a canonical mitogen, is utilized to assess smooth muscle cell proliferation and metabolic remodeling in vitro. These protocols are highly relevant for researchers aiming to replicate or extend the PASMC proliferation assays described in Yi et al. (2026).
Limitations and Transferability
While the study delivers compelling mechanistic evidence, several limitations should be noted:- Pre-publication Status: The results are from an in-press manuscript and may be subject to further revision.
- Species and Model Specificity: The primary findings derive from human cell lines and rodent models; their direct applicability to human PH patients will require further clinical validation.
- Complexity of In Vivo Regulation: While the ALDOB–DRP1 axis is clearly implicated, additional regulatory mechanisms may contribute to PH pathogenesis in vivo, and the potential off-target effects of manipulating lactylation remain to be fully characterized.